Nick chats to Dr Richard Lessells (infectious diseases specialist and group leader) at the KwaZulu- Natal Research Innovation and Sequencing Platform (KRISP) about the large-scale trials showing that the Pfizer/BioNTech vaccine is 90% effective
Nick chats to Dr Richard Lessells (infectious diseases specialist and group leader) at the KwaZulu- Natal Research Innovation and Sequencing Platform (KRISP) about the large-scale trials showing that the Pfizer/BioNTech vaccine is 90% effective